Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Novel Arm Restraint For Critically Ill Patients To Reduce Immobility, Sedation, Agitation and Cognitive Impairment

NCT04067622 is registered in ClinicalTrials.gov with University of Vermont as lead sponsor.

NCT NCT04067622
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04067622 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Novel Arm Restraint For Critically Ill Patients To Reduce Immobility, Sedation, Agitation and Cognitive Impairment
Lead sponsor
University of Vermont
Phase
Not applicable
Overall status
Completed
Start date
September 1, 2019
Completion date
December 28, 2021
Enrollment
58 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

acute respiratory failure, ards, critical illness, encephalopathy, sepsis